NPJ Breast Cancer

Genomic characterization of ER-positive primary tumors and corresponding relapses identifies potentially targetable alterations.

Schagerholm Stanev C, Robertson S, Toosi H, ..., Lagergren J, Hartman J

NPJ Breast Cancer 12 (1) - [2026-08-30; online 2026-08-30]

NGI Short read [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response.

Alamukii NA, Kovács A, Raghavan S, ..., Helou K, Parris TZ

NPJ Breast Cancer 11 (1) 142 [2025-12-12; online 2025-12-12]

Spatial Proteomics [Service]

High prevalence of somatic PIK3CA and TP53 pathogenic variants in the normal mammary gland tissue of sporadic breast cancer patients revealed by duplex sequencing.

Kostecka A, Nowikiewicz T, Olszewski P, ..., Dumanski JP, Piotrowski A

NPJ Breast Cancer 8 (1) 76 [2022-06-29; online 2022-06-29]

NGI SNP genotyping [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study.

Zerdes I, Simonetti M, Matikas A, ..., Crosetto N, Foukakis T

NPJ Breast Cancer 7 (1) 144 [2021-11-19; online 2021-11-19]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics [Service] Clinical Genomics Stockholm [Service] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]